Form4insider filings, from the source

SEC Form 4 · accession 0001645627-15-000008

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Oct 28, 2015
Accepted (ET)
Dec 29, 2015 · 1:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockOct 28, 2015P500$0.08A19,619,201D
Common StockOct 29, 2015P200$0.10A19,619,401D
Common StockNov 3, 2015P1,000$0.09A19,620,401D
Common StockNov 19, 2015P500$0.0799A19,620,901D
Common StockNov 20, 2015P500$0.0799A19,621,901D
Common StockNov 25, 2015P722$0.08A19,622,623D
Common StockNov 25, 2015P500$0.08A19,623,123D
Common StockNov 30, 2015P500$0.08A19,623,623D
Common StockDec 1, 2015P500$0.075A19,624,123D
Common StockDec 1, 2015P200$0.075A19,624,323D
Common StockDec 1, 2015P200$0.075A19,624,523D
Common StockDec 2, 2015P200$0.0799A19,624,723D
Common StockDec 2, 2015P200$0.09A19,624,923D
Common StockDec 2, 2015P200$0.1245A19,625,123D

Table II — derivative securities

No Table II lines on this filing.